Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT)-Reference-Cited by-同舟云学术

Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT)

Published:2010-01 Issue:10 Volume:23 Page:
ISSN:0334-018X
Container-title:Journal of Pediatric Endocrinology and Metabolism
language:
Short-container-title:

Author:

Reiter Edward O.,Mauras Nelly,McCormick Ken,Kulshreshtha Bindu,Amrhein James,De Luca Francesco,O'Brien Sandra,Armstrong Jon,Melezinkova Helena

Publisher

Walter de Gruyter GmbH

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health

Link

https://www.degruyter.com/document/doi/10.1515/jpem.2010.161/pdf

Reference28 articles.

1. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes

2. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty.

3. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

4. Association of testosterone and dihydrotestosterone with externalizing behavior in adolescent boys and girls

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bicalutamide: A review;Journal of Cutaneous and Aesthetic Surgery;2024-09-06

2. Presentation and Care for Children with Peripheral Precocious Puberty;Endocrinology and Metabolism Clinics of North America;2024-06

3. Placing a Report of Bicalutamide-Induced Hepatotoxicity in the Context of Current Standards of Care for Transgender Adolescents;Journal of Adolescent Health;2024-01

4. A retrospective review of the use of bicalutamide in transfeminine youth; a single center experience;International Journal of Transgender Health;2023-12-15

5. Anastrozole - off‑label use in men;Farmacie pro praxi;2023-03-03